Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent advances in the molecular prognostication of meningiomas.
Wang EJ, Haddad AF, Young JS, Morshed RA, Wu JPH, Salha DM, Butowski N, Aghi MK. Wang EJ, et al. Front Oncol. 2023 Jan 4;12:910199. doi: 10.3389/fonc.2022.910199. eCollection 2022. Front Oncol. 2023. PMID: 36686824 Free PMC article. Review.
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF, Weller M, van den Bent M, Beck J, Hervey-Jumper S, Molinaro AM, Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau SJ, Chang SM, Berger MS, Esquenazi Y, Tonn JC. Karschnia P, et al. Among authors: morshed ra. Neuro Oncol. 2023 Sep 5;25(9):1672-1685. doi: 10.1093/neuonc/noad074. Neuro Oncol. 2023. PMID: 37253096 Free PMC article.
TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group.
Karschnia P, Young JS, Dono A, Häni L, Juenger ST, Sciortino T, Bruno F, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, van den Bent M, Weller M, Berger MS, Chang SM, Tonn JC. Karschnia P, et al. Among authors: morshed ra. Neurooncol Adv. 2022 Sep 29;4(1):vdac158. doi: 10.1093/noajnl/vdac158. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36325373 Free PMC article. No abstract available.
Identification of risk factors associated with leptomeningeal disease after resection of brain metastases.
Morshed RA, Saggi S, Cummins DD, Molinaro AM, Young JS, Viner JA, Villanueva-Meyer JE, Goldschmidt E, Boreta L, Braunstein SE, Chang EF, McDermott MW, Berger MS, Theodosopoulos PV, Hervey-Jumper SL, Aghi MK, Daras M. Morshed RA, et al. J Neurosurg. 2023 Jan 13;139(2):402-413. doi: 10.3171/2022.12.JNS221490. Print 2023 Aug 1. J Neurosurg. 2023. PMID: 36640095 Free PMC article.
CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.
Morshed RA, Nguyen MP, Cummins DD, Saggi S, Young JS, Haddad AF, Goldschmidt E, Chang EF, McDermott MW, Berger MS, Theodosopoulos PV, Hervey-Jumper SL, Daras M, Aghi MK. Morshed RA, et al. Neurooncol Adv. 2023 Jan 28;5(1):vdad007. doi: 10.1093/noajnl/vdad007. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 36915611 Free PMC article.
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
Hervey-Jumper SL, Zhang Y, Phillips JJ, Morshed RA, Young JS, McCoy L, Lafontaine M, Luks T, Ammanuel S, Kakaizada S, Egladyous A, Gogos A, Villanueva-Meyer J, Shai A, Warrier G, Rice T, Crane J, Wrensch M, Wiencke JK, Daras M, Oberheim Bush NA, Taylor JW, Butowski N, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Jakola AS, Kavouridis VK, Nawabi N, Solheim O, Smith T, Berger MS, Molinaro AM. Hervey-Jumper SL, et al. J Clin Oncol. 2023 Apr 10;41(11):2029-2042. doi: 10.1200/JCO.21.02929. Epub 2023 Jan 4. J Clin Oncol. 2023. PMID: 36599113 Free PMC article. Clinical Trial.
141 results